
Catherine Serke Williams
Examiner (ID: 6974, Phone: (571)272-4970 , Office: P/3993 )
| Most Active Art Unit | 3763 |
| Art Unit(s) | 3763, 3762, 3731, 3993 |
| Total Applications | 1016 |
| Issued Applications | 626 |
| Pending Applications | 245 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7545583
[patent_doc_number] => 08053555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Carbon nanotube binding peptides'
[patent_app_type] => utility
[patent_app_number] => 12/895955
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10328
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895955
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895955 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6149310
[patent_doc_number] => 20110020905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/895967
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10362
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020905.pdf
[firstpage_image] =>[orig_patent_app_number] => 12895967
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/895967 | Carbon nanotube binding peptides | Sep 30, 2010 | Issued |
Array
(
[id] => 6120643
[patent_doc_number] => 20110077164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'EXPRESSION PROFILING PLATFORM TECHNOLOGY'
[patent_app_type] => utility
[patent_app_number] => 12/889935
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9574
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077164.pdf
[firstpage_image] =>[orig_patent_app_number] => 12889935
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/889935 | EXPRESSION PROFILING PLATFORM TECHNOLOGY | Sep 23, 2010 | Abandoned |
Array
(
[id] => 5977592
[patent_doc_number] => 20110071046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'MATRIX SCREENING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/888862
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10948
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071046.pdf
[firstpage_image] =>[orig_patent_app_number] => 12888862
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/888862 | MATRIX SCREENING METHOD | Sep 22, 2010 | Abandoned |
Array
(
[id] => 6083648
[patent_doc_number] => 20110144031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same'
[patent_app_type] => utility
[patent_app_number] => 12/923463
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4732
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144031.pdf
[firstpage_image] =>[orig_patent_app_number] => 12923463
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/923463 | Pharmaceutical composition for inducing damages of endothelial cells and treating tumor and method for treating tumor by using the same | Sep 22, 2010 | Abandoned |
Array
(
[id] => 7818502
[patent_doc_number] => 20120065122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Pharmaceutical Composition and Method for Modulating Slow Myosin'
[patent_app_type] => utility
[patent_app_number] => 12/882546
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 1866
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065122.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882546
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882546 | Pharmaceutical Composition and Method for Modulating Slow Myosin | Sep 14, 2010 | Abandoned |
Array
(
[id] => 6000644
[patent_doc_number] => 20110117073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'Protein Kinase Conjugates and Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/882484
[patent_app_country] => US
[patent_app_date] => 2010-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 42036
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117073.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882484 | Protein kinase conjugates and inhibitors | Sep 14, 2010 | Issued |
Array
(
[id] => 5986706
[patent_doc_number] => 20110098235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'ANTINEOPLASTIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/869314
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6584
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098235.pdf
[firstpage_image] =>[orig_patent_app_number] => 12869314
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/869314 | Antineoplastic peptides | Aug 25, 2010 | Issued |
Array
(
[id] => 6389872
[patent_doc_number] => 20100317837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES'
[patent_app_type] => utility
[patent_app_number] => 12/869198
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17725
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20100317837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12869198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/869198 | IDENTIFICATION OF NOVEL BROADLY CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES USING SEQUENTIAL ANTIGEN PANNING OF PHAGE DISPLAY LIBRARIES | Aug 25, 2010 | Abandoned |
Array
(
[id] => 9983791
[patent_doc_number] => 09029505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Modified vasoactive intestinal peptides'
[patent_app_type] => utility
[patent_app_number] => 12/857103
[patent_app_country] => US
[patent_app_date] => 2010-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13714
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12857103
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/857103 | Modified vasoactive intestinal peptides | Aug 15, 2010 | Issued |
Array
(
[id] => 6136138
[patent_doc_number] => 20110009291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY'
[patent_app_type] => utility
[patent_app_number] => 12/846646
[patent_app_country] => US
[patent_app_date] => 2010-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14547
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009291.pdf
[firstpage_image] =>[orig_patent_app_number] => 12846646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/846646 | METHODS AND COMPOSITIONS FOR INCREASING MEMBRANE PERMEABILITY | Jul 28, 2010 | Abandoned |
Array
(
[id] => 5959531
[patent_doc_number] => 20110183918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'Method of Treating Leukemia Using Rcie Prolamin'
[patent_app_type] => utility
[patent_app_number] => 12/845039
[patent_app_country] => US
[patent_app_date] => 2010-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4726
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183918.pdf
[firstpage_image] =>[orig_patent_app_number] => 12845039
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/845039 | Method of Treating Leukemia Using Rcie Prolamin | Jul 27, 2010 | Abandoned |
Array
(
[id] => 6183444
[patent_doc_number] => 20110123448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'OIL BODY CARRIERS, USES IN TARGET THERAPY AND/OR DETECTION OF THE SAME, AND FUSION PROTEINS COMPRISED THEREIN'
[patent_app_type] => utility
[patent_app_number] => 12/841500
[patent_app_country] => US
[patent_app_date] => 2010-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 9993
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20110123448.pdf
[firstpage_image] =>[orig_patent_app_number] => 12841500
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/841500 | OIL BODY CARRIERS, USES IN TARGET THERAPY AND/OR DETECTION OF THE SAME, AND FUSION PROTEINS COMPRISED THEREIN | Jul 21, 2010 | Abandoned |
Array
(
[id] => 5993477
[patent_doc_number] => 20110015130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/838926
[patent_app_country] => US
[patent_app_date] => 2010-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 11976
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015130.pdf
[firstpage_image] =>[orig_patent_app_number] => 12838926
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/838926 | Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof | Jul 18, 2010 | Abandoned |
Array
(
[id] => 6602257
[patent_doc_number] => 20100322979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 12/820683
[patent_app_country] => US
[patent_app_date] => 2010-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5757
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0322/20100322979.pdf
[firstpage_image] =>[orig_patent_app_number] => 12820683
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/820683 | Peptidomimetic Resorbable Peptide-Polymer Hybrid Polyester Nanoparticles | Jun 21, 2010 | Abandoned |
Array
(
[id] => 10898103
[patent_doc_number] => 08921317
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-12-30
[patent_title] => 'Nano-recombinant fibrinogen for fibrin sealants'
[patent_app_type] => utility
[patent_app_number] => 12/814078
[patent_app_country] => US
[patent_app_date] => 2010-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 6566
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12814078
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/814078 | Nano-recombinant fibrinogen for fibrin sealants | Jun 10, 2010 | Issued |
Array
(
[id] => 7651830
[patent_doc_number] => 20110301099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules'
[patent_app_type] => utility
[patent_app_number] => 12/802354
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1892
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301099.pdf
[firstpage_image] =>[orig_patent_app_number] => 12802354
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/802354 | Method for enhancing penetration of lipid insoluble medicaments through cell membranes using small S-Allyl-containing molecules with phospholipid permeability as carrier molecules | Jun 3, 2010 | Abandoned |
Array
(
[id] => 6062073
[patent_doc_number] => 20110200560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'NON-IONIC SELF-ASSEMBLING PEPTIDES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/787546
[patent_app_country] => US
[patent_app_date] => 2010-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11194
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20110200560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12787546
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/787546 | NON-IONIC SELF-ASSEMBLING PEPTIDES AND USES THEREOF | May 25, 2010 | Abandoned |
Array
(
[id] => 7807174
[patent_doc_number] => 20120058127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections'
[patent_app_type] => utility
[patent_app_number] => 13/266799
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9567
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058127.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266799
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266799 | PAR2 agonists for use in the treatment or prevention of influenza virus type A infections | May 2, 2010 | Issued |
Array
(
[id] => 7777243
[patent_doc_number] => 20120040365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'NEW COMPETENCE STIMULATING PEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 13/266103
[patent_app_country] => US
[patent_app_date] => 2010-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9983
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040365.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266103
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266103 | NEW COMPETENCE STIMULATING PEPTIDE | Apr 27, 2010 | Abandoned |